HK1216117A1 - 角質層狀態的評價方法及關於化妝品的角質層改善效果的評價方法 - Google Patents

角質層狀態的評價方法及關於化妝品的角質層改善效果的評價方法

Info

Publication number
HK1216117A1
HK1216117A1 HK16104143.0A HK16104143A HK1216117A1 HK 1216117 A1 HK1216117 A1 HK 1216117A1 HK 16104143 A HK16104143 A HK 16104143A HK 1216117 A1 HK1216117 A1 HK 1216117A1
Authority
HK
Hong Kong
Prior art keywords
evaluating
horny layer
improving effect
cosmetic preparation
state
Prior art date
Application number
HK16104143.0A
Other languages
English (en)
Inventor
Eiichiro Yagi
Ichiro Iwai
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of HK1216117A1 publication Critical patent/HK1216117A1/zh

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/44Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/442Evaluating skin mechanical properties, e.g. elasticity, hardness, texture, wrinkle assessment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/44Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/443Evaluating skin constituents, e.g. elastin, melanin, water
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4848Monitoring or testing the effects of treatment, e.g. of medication
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6486Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • G01N33/5088Supracellular entities, e.g. tissue, organisms of vertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/42Colour properties
    • A61K2800/43Pigments; Dyes
    • A61K2800/434Luminescent, Fluorescent; Optical brighteners; Photosensitizers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • G01N2001/302Stain compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Cosmetics (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
HK16104143.0A 2013-01-21 2016-04-12 角質層狀態的評價方法及關於化妝品的角質層改善效果的評價方法 HK1216117A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013008590A JP6243123B2 (ja) 2013-01-21 2013-01-21 角層状態の評価方法、及び化粧料の角層改善効果についての評価方法
PCT/JP2014/051110 WO2014112643A1 (ja) 2013-01-21 2014-01-21 角層状態の評価方法、及び化粧料の角層改善効果についての評価方法

Publications (1)

Publication Number Publication Date
HK1216117A1 true HK1216117A1 (zh) 2016-10-14

Family

ID=51209728

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16104143.0A HK1216117A1 (zh) 2013-01-21 2016-04-12 角質層狀態的評價方法及關於化妝品的角質層改善效果的評價方法

Country Status (8)

Country Link
US (1) US9970848B2 (zh)
EP (1) EP2947457A4 (zh)
JP (1) JP6243123B2 (zh)
KR (1) KR102105222B1 (zh)
CN (1) CN105026929B (zh)
HK (1) HK1216117A1 (zh)
TW (1) TWI596338B (zh)
WO (1) WO2014112643A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019171597A1 (ja) * 2018-03-09 2019-09-12 株式会社資生堂 皮膚バリア機能を評価する方法
WO2019219390A1 (en) 2018-05-17 2019-11-21 Unilever N.V. Method of evaluating efficacy of cosmetic cleansing compositions
WO2020052994A1 (en) 2018-09-12 2020-03-19 Unilever N.V. Method of evaluating efficacy of cosmetic compositions
EP3973271A1 (en) 2018-09-14 2022-03-30 Unilever IP Holdings B.V. Evaluating the efficacy of leave-on cosmetic compositions to protect skin from pollutants
WO2020235668A1 (ja) * 2019-05-23 2020-11-26 ポーラ化成工業株式会社 角層細胞間の接着タンパク質の増減に影響を与える成分のスクリーニング方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004340935A (ja) * 2003-04-21 2004-12-02 Shiseido Co Ltd 角層における酸化タンパク質の評価方法
EP1617215A4 (en) * 2003-04-21 2007-09-26 Shiseido Co Ltd METHOD OF ESTIMATING OXIDIZED PROTEIN IN A HORN CELL LAYER
JP4526839B2 (ja) * 2004-03-05 2010-08-18 株式会社資生堂 角層中の酸化タンパク質を指標とする角層の透明性・保水性を評価する方法
JP2006349372A (ja) * 2005-06-13 2006-12-28 Shiseido Co Ltd 角層中の酸化タンパク質を指標とする肌の柔軟性・弾力性を評価する方法
JP4469762B2 (ja) 2005-07-26 2010-05-26 株式会社資生堂 敏感肌の評価方法及びその評価キット
JP2007263655A (ja) 2006-03-28 2007-10-11 Pola Chem Ind Inc コンゴレッドによる皮膚の鑑別方法
JP2009036555A (ja) * 2007-07-31 2009-02-19 Shiseido Co Ltd 角層カルボニル化タンパク質の検出による皮膚疾患簡易検査方法
FR2945943B1 (fr) 2009-06-01 2015-04-03 Lvmh Rech Utilisation d'un extrait vegetal riche en polyphenols comme agent antioxydant en association avec un agent hydratant ou humectant
JP5343882B2 (ja) * 2010-02-15 2013-11-13 御木本製薬株式会社 角層細胞の重層剥離度の鑑別方法
JP5491228B2 (ja) * 2010-02-16 2014-05-14 御木本製薬株式会社 染色液および染色方法
WO2012109319A1 (en) * 2011-02-08 2012-08-16 Avery Dennison Corporation Comprehensive skin testing
JP2012202969A (ja) * 2011-03-28 2012-10-22 Shiseido Co Ltd 角層の収縮状態を測定することによる肌マイクロレリーフ評価法

Also Published As

Publication number Publication date
JP2014139540A (ja) 2014-07-31
WO2014112643A1 (ja) 2014-07-24
KR102105222B1 (ko) 2020-04-27
US20150362412A1 (en) 2015-12-17
CN105026929B (zh) 2017-03-08
TWI596338B (zh) 2017-08-21
CN105026929A (zh) 2015-11-04
JP6243123B2 (ja) 2017-12-06
TW201435343A (zh) 2014-09-16
EP2947457A4 (en) 2016-06-15
EP2947457A1 (en) 2015-11-25
US9970848B2 (en) 2018-05-15
KR20150110485A (ko) 2015-10-02

Similar Documents

Publication Publication Date Title
IL290547A (en) Antibodies and methods of use
IL244495B (en) Anti-alpha-synuclein antibodies and methods of use
GB201320723D0 (en) Composition and methods of treatment
EP2999474A4 (en) THERAPEUTIC AND METHOD OF USE
HK1225612A1 (zh) 抗ly6e抗體及使用方法
EP3065730A4 (en) Vasodilator formulation and method of use
GB201312669D0 (en) Microneedles and method of manufacture
PL2988756T5 (pl) Formulacja środka kontrastowego i powiązany sposób jego wytwarzania
HK1221641A1 (zh) 疫苗組合物及使用方法
EP2838633A4 (en) DEMULATORY COMPOSITION AND METHOD FOR USE THEREOF
EP2991627A4 (en) BLOOD SUCCANTED COMPOSITION AND METHOD OF USE
SG11201507359SA (en) Flavivirus neutralizing antibodies and methods of use thereof
HK1216117A1 (zh) 角質層狀態的評價方法及關於化妝品的角質層改善效果的評價方法
SG11201510300RA (en) Compositions and methods for treating skin
EP2844219A4 (en) SENSITIZING COMPOSITION AND METHOD OF USE
GB201314902D0 (en) Microneedle device and method of preparation
SG11201603190QA (en) Acupressure pillow and method of applying acupressure
GB201518035D0 (en) Prebiotic composition and method of its use
GB201310349D0 (en) Composition and method of use thereof
GB201301928D0 (en) Composition and method of use thereof
GB201308574D0 (en) Applicator device and method of use thereof
AU2013904256A0 (en) Vasodilator formulation and method of use
AU2013901754A0 (en) Fabric care composition and method of use thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220117